Diphtheria Clinical Trials
224 clinical trials for Diphtheria across international registries, including 4 currently recruiting participants. Compare status, phase, eligibility criteria and locations.
- A Phase II/III Study to Evaluate the Immunogenicity, Safety and Lot-to-lot Consistency of LBVD, a Fully Liquid Hexavalent Diphtheria-tetanus-whole Cell Pertussis-hepatitis B-poliovirus-Haemophilus Influenzae Type b Conjugate (DTwP-HepB-IPV-Hib) Vaccine, in Healthy Infants as Primary Series — RECRUITING · PHASE2
- Safety and Immunogenicity of DTaP-IPV/Hib Pentavalent Vaccine in Chinese 2-month-old Infants — RECRUITING · NA
- Phase I Clinical Trial of Diphtheria-Tetanus-acellular Pertussis Component Combined Vaccine — RECRUITING · PHASE1
- Immunity against vaccine-preventable diseases in the homeless population in Germany — RECRUITING
- A Clinical Trial of Adsorbed Cell-free DPT Vaccine (5-component) (for People Aged 6 Years and Above) — COMPLETED · PHASE1
- A Clinical Trials of Adsorbed Cell-free DPT Vaccine (Five-component) — COMPLETED · PHASE2
- A Clinical Study on Immunogenicity Persistence of Adsorbed 5-component Acellular Pertussis, Diphtheria and Tetanus Combined Vaccine — NOT_YET_RECRUITING
- Maternal Immunization With Tetanus Toxoid, Reduced Diphtheria Toxoid, Reduced-dose (2 µg) Recombinant Pertussis Vaccine (TdaP2gen) and Its Effect on the Immune Response in Thai Infants up to 15-18 Months Old — NOT_YET_RECRUITING · PHASE4
- A Phase I Clinical Trial of Absorbed Acellular Pertussis (Two-Component) Diphtheria-Tetanus Combined Vaccine (For Adults and Adolescents) — NOT_YET_RECRUITING · PHASE1
- Safety Monitoring of Boostagen® Vaccine in Thailand — COMPLETED
- Phase I/II Clinical Trial of Diphtheria-Tetanus-Pertussis (Reduced Dose) Vaccine — NOT_YET_RECRUITING · PHASE1
- Confirmatory Study of BK1310 in Healthy Infants — COMPLETED · PHASE3
- Study of BK1301 (DTaP Vaccine) as a Booster in Adolescents — COMPLETED · PHASE3
- PFAS Exposure and Immune Response to Vaccination in Adults — COMPLETED · PHASE4
- A Phase 3 Study of BIBP Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed — ACTIVE_NOT_RECRUITING · PHASE3
- Study on the Safety and Immunogenicity of Boostrix Vaccine in Pregnant Malian Women and Their Infants — COMPLETED · PHASE2
- Sero-epidemiological Survey of England in 2019/2020 - COVID-19 — COMPLETED
- Study to Evaluate the Immunogenicity of LR20062 Compared to Control When Administered Intramuscularly in Healthy Infants At 2, 4, 6 Months of Age — NOT_YET_RECRUITING · PHASE2
- A Study to Evaluate Immunogenicity and Safety of GlaxoSmithKline (GSK)'s Infanrix Hexa Vaccine (DTPa-HBV-IPV/Hib) Versus MCM Vaccine BV's Vaxelis Vaccine (DTaP5-HBV-IPV-Hib) in Healthy Infants and Toddlers — COMPLETED · PHASE4
- Impact of Boostrix™ Maternal Vaccination on Morbidity and Mortality of Pertussis Disease in Infants ≤6 Weeks of Age, in Bogota, Colombia. — COMPLETED
- Immunogenicity and Safety of Vaccine Against Tetanus and Diphtheria. — OTHER · PHASE3
- A Study to Evaluate Safety and Immunogenicity of APV006 in Healthy Adults — OTHER · PHASE1
- Vaccine -diphthEria -tetaNus -Acellular pertUssis-inactivated polioviruS — COMPLETED · PHASE3
- Study to Evaluate the Immunogenicity and Safety of LBVD(Hexavalent Vaccine), Given to Healthy Infants at Primary Series — OTHER · PHASE2
- Post-marketing Surveillance to Assess the Safety of Infanrix-IPV Vaccine Among Infants and Children in Korea — COMPLETED
- Phase I Clinical Trial of Diphtheria, Tetanus and Acellular Pertussis (Three Components) Combined Vaccine, Adsorbed . — COMPLETED · PHASE1
- Randomized Controlled Trial of the Impact of Mobile Phone Delivered Reminders and Travel Subsidies to Improve Childhood Immunization Coverage Rates and Timeliness in Western Kenya — COMPLETED · NA
- A PHASE 1 RANDOMIZED, CONTROLLED, OBSERVER-BLINDED, MULTICENTER STUDY TO EVALUATE SAFETY, TOLERABILITY AND IMMUNOGENICITY OF AN INVESTIGATIONAL ADJUVANTED TETANUS/DIPHTHERIA/PERTUSSIS BOOSTER VACCINE (TDAP-1018) IN ACELLULAR PERTUSSIS VACCINE PRIMED HEALTHY VOLUNTEERS 18 TO 23 YEARS OF AGE — NOT_YET_RECRUITING · PHASE1
- Post Marketing Surveillance for ADACEL™ in South Korea — COMPLETED · PHASE4
- Safety and Immunogenicity in Adults of Revaccination With Adacel® Vaccine 10 Years After a Previous Dose — COMPLETED · PHASE4
- Surveillance Program to Determine Product Specific Rates of Invasive Hib Disease — COMPLETED
- DTaP-IPV/Hib Vaccine Primary & Booster Vaccinations Versus Co-administration of DTaP-IPV and Hib Vaccine in Japanese Infants — COMPLETED · PHASE3
- DTaP-IPV-HB-PRP-T Combined Vaccine as a Primary Series and a Second Year of Life Booster in HIV-Exposed Infected and Uninfected Infants — COMPLETED · PHASE3
- Immunogenicity and Safety of Sanofi Pasteur's Combined Vaccine Given as a Three-Dose Primary Series at 2, 3,4 Months of Age and Followed by a Booster Dose Given at 16 to 17 Months of Age in Vietnamese Infants Who Previously Received a Dose of Hepatitis B Vaccine at Birth or Within 1 Week After Birth — COMPLETED · PHASE3
- Regulatory Post-Marketing Surveillance Study for TETRAXIM™ — COMPLETED · PHASE4
- Study of Tetanus Toxoid, Reduced Diphtheria Toxoid, and Acellular Pertussis Vaccine Adsorbed in Healthy Subjects — COMPLETED · PHASE1
- Study to Evaluate Antibody Persistence in Children Previously Vaccinated With Infanrix Hexa™ or Infanrix-IPV/Hib™ — COMPLETED · PHASE4
- To Evaluate the Immunogenicity and Safety of 'BR-TD-1001' Administered Intramuscularly in Healthy Children — COMPLETED · PHASE3
- To Evaluate the Immunogenicity and Safety of DTaP-IPV Vaccine Administered as a Boosting Dose to Healthy Children of 4-6 Years — OTHER · PHASE3
- Safety and Immunogenicity of a Booster Dose of New Formulations of GlaxoSmithKline Biologicals' DTPa-HBV-IPV/Hib Vaccine (GSK217744) — COMPLETED · PHASE2
- Persistence Study of GSK Biologicals' Tdap Vaccine 1, 3, 5 and 9 Years Following Administration as an Initial Single Dose in Healthy Young Adults and to Evaluate the Immunogenicity and Safety of Boostrix as a Second Dose of Tdap, When Administered at Year 9 — COMPLETED · PHASE3
- Evaluation of an Infant Immunization Encouragement Program in Nigeria — COMPLETED · NA
- Response to GSK Biologicals' Tritanrix-HepB/Hib-MenAC Vacc (4th Dose) at 15-24m & Mencevax ACWY at 24-30m — COMPLETED · PHASE3
- Safety Study of Tritanrix-HepB/Hib-MenAC, Tritanrix-HepB/Hiberix, and Mencevax ACWY Vaccines in Children — COMPLETED · PHASE3
- Evaluate the Safety Pharmacokinetics of a Human Monoclonal Antibody S315 Against Diphtheria Toxin in Healthy Subjects — COMPLETED · PHASE1
- Immune Response and Safety Comparison of 3 Lots of GSK Biologicals' DTaP-IPV Candidate Vaccine to DTaP + IPV Vaccines — COMPLETED · PHASE3
- A Study to Evaluate the Safety and Efficacy(Immunogenicity) of GC3111 in Healthy Adults — OTHER · PHASE2
- Safety of GSK Biologicals' Infanrix-IPV+HibTM Vaccine in Healthy Vietnamese Toddlers — COMPLETED · PHASE3
- Immunogenicity and Safety Study of GlaxoSmithKline Biologicals' GSK2202083A Vaccine Administered as a Booster Dose — COMPLETED · PHASE2
- Evaluation of Immunogenicity and Safety of a Booster Dose of Infanrix Hexa™ in Healthy Infants Born to Mothers Vaccinated With Boostrix™ During Pregnancy or Immediately Post-delivery — COMPLETED · PHASE4
Refine this search